{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:49:45Z","timestamp":1795027785654,"version":"4.10.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L023784\/2"],"award-info":[{"award-number":["MR\/L023784\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dolby Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this perspective we draw together the data from the genome wide association studies for Alzheimer\u2019s disease, Parkinson\u2019s disease and the tauopathies and reach the conclusion that in each case, most of the risk loci are involved in the clearance of the deposited proteins: in Alzheimer\u2019s disease, the microglial removal of A\u03b2, in the synucleinopathies, the lysosomal clearance of synuclein and in the tauopathies, the removal of tau protein by the ubiquitin proteasome. We make the point that most loci identified through genome wide association studies are not strictly pathogenic but rather relate to failures to remove age related damage. We discuss these issues in the context of copathologies in elderly individuals and the prediction of disease through polygenic risk score analysis at different ages. Finally, we discuss what analytic approaches are needed now that we have adequately sized case control analyses in white populations.<\/jats:p>","DOI":"10.1038\/s41380-025-02911-7","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:42:04Z","timestamp":1738161724000},"page":"2748-2753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure"],"prefix":"10.1038","volume":"30","author":[{"given":"John","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1784-5483","authenticated-orcid":false,"given":"Valentina","family":"Escott-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2911_CR1","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/s41380-023-02076-1","volume":"28","author":"JC Lambert","year":"2023","unstructured":"Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C. Step by step: towards a better understanding of the genetic architecture of Alzheimer\u2019s disease. Mol Psychiatry. 2023;28:2716\u201327.","journal-title":"Mol Psychiatry"},{"key":"2911_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease. PLoS one. 2010;5:e13950.","journal-title":"PLoS one"},{"key":"2911_CR3","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1093\/hmg\/ddz183","volume":"28","author":"A Singleton","year":"2019","unstructured":"Singleton A, Hardy J. Progress in the genetic analysis of Parkinson\u2019s disease. Hum Mol Genet. 2019;28:R215\u20138.","journal-title":"Hum Mol Genet"},{"key":"2911_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3389\/fnins.2019.01304","volume":"13","author":"J Hardy","year":"2019","unstructured":"Hardy J. Failures in protein clearance partly underlie late onset neurodegenerative diseases and link pathology to genetic risk. Front Neurosci. 2019;13:1304.","journal-title":"Front Neurosci"},{"key":"2911_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14348\/molcells.2017.0115","volume":"40","author":"CH Ji","year":"2017","unstructured":"Ji CH, Kwon YT. Crosstalk and interplay between the ubiquitin-proteasome system and autophagy. Mol Cell. 2017;40:441\u20139.","journal-title":"Mol Cell"},{"key":"2911_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","volume":"584","author":"VI Korolchuk","year":"2010","unstructured":"Korolchuk VI, Menzies FM, Rubinsztein DC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 2010;584:1393\u20138.","journal-title":"FEBS Lett"},{"key":"2911_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/antiox9080740","volume":"9","author":"P Michalska","year":"2020","unstructured":"Michalska P, Leon R. When it comes to an end: oxidative stress crosstalk with protein aggregation and neuroinflammation induce neurodegeneration. Antioxidants. 2020;9:740.","journal-title":"Antioxidants"},{"key":"2911_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600947","volume":"2","author":"R Freer","year":"2016","unstructured":"Freer R, Sormanni P, Vecchi G, Ciryam P, Dobson CM, Vendruscolo M. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer\u2019s disease. Sci Adv. 2016;2:e1600947.","journal-title":"Sci Adv"},{"key":"2911_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38:24\u20136.","journal-title":"Nat Genet"},{"key":"2911_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302:841.","journal-title":"Science"},{"key":"2911_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-021-02320-4","volume":"142","author":"D Wallon","year":"2021","unstructured":"Wallon D, Boluda S, Rovelet-Lecrux A, Thierry M, Lagarde J, Miguel L, et al. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers. Acta Neuropathol. 2021;142:259\u201378.","journal-title":"Acta Neuropathol"},{"key":"2911_CR12","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","volume":"10","author":"M Farrer","year":"2001","unstructured":"Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, et al. alpha-Synuclein gene haplotypes are associated with Parkinson\u2019s disease. Hum Mol Genet. 2001;10:1847\u201351.","journal-title":"Hum Mol Genet"},{"key":"2911_CR13","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1093\/hmg\/ddh093","volume":"13","author":"A Singleton","year":"2004","unstructured":"Singleton A, Myers A, Hardy J. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum Mol Genet. 2004;13:R123\u20136.","journal-title":"Hum Mol Genet"},{"key":"2911_CR14","doi-asserted-by":"publisher","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","volume":"5","author":"R Potter","year":"2013","unstructured":"Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, et al. Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med. 2013;5:189ra77.","journal-title":"Sci Transl Med"},{"key":"2911_CR15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science"},{"key":"2911_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-neuro-072116-031357","volume":"40","author":"X Fan","year":"2017","unstructured":"Fan X, Wheatley EG, Villeda SA. Mechanisms of hippocampal aging and the potential for rejuvenation. Annu Rev Neurosci. 2017;40:251\u201372.","journal-title":"Annu Rev Neurosci"},{"key":"2911_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tins.2006.07.001","volume":"29","author":"WJ Streit","year":"2006","unstructured":"Streit WJ. Microglial senescence: does the brain\u2019s immune system have an expiration date? Trends Neurosci. 2006;29:506\u201310.","journal-title":"Trends Neurosci"},{"key":"2911_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain. 2021;144:2186\u201398.","journal-title":"Brain"},{"key":"2911_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0002-9440(10)61119-4","volume":"160","author":"MS Forman","year":"2002","unstructured":"Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM, Trojanowski JQ. Tau and alpha-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam. Am J Pathol. 2002;160:1725\u201331.","journal-title":"Am J Pathol"},{"key":"2911_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology. BMC Med. 2014;12:206.","journal-title":"BMC Med"},{"key":"2911_CR21","doi-asserted-by":"publisher","first-page":"glae118","DOI":"10.1093\/gerona\/glae118","volume":"79","author":"JM Farfel","year":"2024","unstructured":"Farfel JM, Capuano AW, Buchman AS, Schneider JA, Bennett DA. Association of Alzheimer\u2019s disease and other neuropathologies with functional disability in persons with and without dementia. J Gerontol A Biol Sci Med Sci. 2024;79:glae118.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2911_CR22","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197\u2013204.","journal-title":"Neurology"},{"key":"2911_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293:1487\u201391.","journal-title":"Science"},{"key":"2911_CR24","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, et al. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2001;98:12245\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2911_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/1565","volume":"1","author":"J Hardy","year":"1998","unstructured":"Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M. Genetic dissection of Alzheimer\u2019s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci. 1998;1:355\u20138.","journal-title":"Nat Neurosci"},{"key":"2911_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755\u201366.","journal-title":"Acta Neuropathol"},{"key":"2911_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0304-3940(92)90408-Y","volume":"137","author":"PL Lantos","year":"1992","unstructured":"Lantos PL, Luthert PJ, Hanger D, Anderton BH, Mullan M, Rossor M. Familial Alzheimer\u2019s disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer\u2019s disease have the same cytoskeletal pathology. Neurosci Lett. 1992;137:221\u20134.","journal-title":"Neurosci Lett"},{"key":"2911_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","volume":"153","author":"CF Lippa","year":"1998","unstructured":"Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol. 1998;153:1365\u201370.","journal-title":"Am J Pathol"},{"key":"2911_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601\u20137.","journal-title":"Neuron"},{"key":"2911_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnins.2020.00042","volume":"14","author":"YA Abramzon","year":"2020","unstructured":"Abramzon YA, Fratta P, Traynor BJ, Chia R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2020;14:42.","journal-title":"Front Neurosci"},{"key":"2911_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ahg.12520","volume":"87","author":"V Escott-Price","year":"2023","unstructured":"Escott-Price V, Schmidt KM. Pitfalls of predicting age-related traits by polygenic risk scores. Ann Hum Genet. 2023;87:203\u20139.","journal-title":"Ann Hum Genet"},{"key":"2911_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac125","volume":"4","author":"V Escott-Price","year":"2022","unstructured":"Escott-Price V, Hardy J. Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better. Brain Commun. 2022;4:fcac125.","journal-title":"Brain Commun"},{"key":"2911_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.25530","volume":"86","author":"G Leonenko","year":"2019","unstructured":"Leonenko G, Shoai M, Bellou E, Sims R, Williams J, Hardy J, et al. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol. 2019;86:427\u201335.","journal-title":"Ann Neurol"},{"key":"2911_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2990.1984.tb00351.x","volume":"10","author":"DM Mann","year":"1984","unstructured":"Mann DM, Yates PO, Marcyniuk B. Alzheimer\u2019s presenile dementia, senile dementia of Alzheimer type and Down\u2019s syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol. 1984;10:185\u2013207.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2911_CR35","first-page":"83","volume":"3","author":"GD Rabinovici","year":"2017","unstructured":"Rabinovici GD, Carrillo MC, Forman M, DeSanti S, Miller DS, Kozauer N, et al. Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development. Alzheimers Dement. 2017;3:83\u201391.","journal-title":"Alzheimers Dement"},{"key":"2911_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun N, Youle RJ, Finkel T. The mitochondrial basis of aging. Mol Cell. 2016;61:654\u201366.","journal-title":"Mol Cell"},{"key":"2911_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239\u201347.","journal-title":"Nature"},{"key":"2911_CR38","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023;5:2047\u201361.","journal-title":"Nat Metab"},{"key":"2911_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13629","volume":"7","author":"SR Cox","year":"2016","unstructured":"Cox SR, Ritchie SJ, Tucker-Drob EM, Liewald DC, Hagenaars SP, Davies G, et al. Ageing and brain white matter structure in 3513 UK Biobank participants. Nat Commun. 2016;7:13629.","journal-title":"Nat Commun"},{"key":"2911_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1031007","volume":"10","author":"MG Martin","year":"2022","unstructured":"Martin MG, Dotti CG. Plasma membrane and brain dysfunction of the old: do we age from our membranes? Front Cell Dev Biol. 2022;10:1031007.","journal-title":"Front Cell Dev Biol"},{"key":"2911_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0196-0644(86)80388-2","volume":"15","author":"R Gerkin","year":"1986","unstructured":"Gerkin R, Curry SC, Vance MV, Sankowski PW, Meinhart RD. First-order elimination kinetics following baclofen overdose. Ann Emerg Med. 1986;15:843\u20136.","journal-title":"Ann Emerg Med"},{"key":"2911_CR42","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nat Aging. 2021;1:634\u201350.","journal-title":"Nat Aging"},{"key":"2911_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews SJ, Fulton-Howard B, Goate A. Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol. 2020;19:326\u201335.","journal-title":"Lancet Neurol"},{"key":"2911_CR44","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. a meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278:1349\u201356.","journal-title":"JAMA"},{"key":"2911_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41431-018-0273-5","volume":"27","author":"N Tesi","year":"2019","unstructured":"Tesi N, van der Lee SJ, Hulsman M, Jansen IE, Stringa N, van Schoor N, et al. Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer\u2019s disease. Eur J Hum Genet. 2019;27:244\u201353.","journal-title":"Eur J Hum Genet"},{"key":"2911_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11558-2","volume":"10","author":"J Deelen","year":"2019","unstructured":"Deelen J, Evans DS, Arking DE, Tesi N, Nygaard M, Liu X, et al. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat Commun. 2019;10:3669.","journal-title":"Nat Commun"},{"key":"2911_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng0194-29","volume":"6","author":"F Schachter","year":"1994","unstructured":"Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29\u201332.","journal-title":"Nat Genet"},{"key":"2911_CR48","first-page":"226","volume":"26","author":"JN Foo","year":"2017","unstructured":"Foo JN, Tan LC, Irwan ID, Au WL, Low HQ, Prakash KM, et al. Genome-wide association study of Parkinson\u2019s disease in East Asians. Hum Mol Genet. 2017;26:226\u201332.","journal-title":"Hum Mol Genet"},{"key":"2911_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/YPG.0000000000000090","volume":"25","author":"A Hirano","year":"2015","unstructured":"Hirano A, Ohara T, Takahashi A, Aoki M, Fuyuno Y, Ashikawa K, et al. A genome-wide association study of late-onset Alzheimer\u2019s disease in a Japanese population. Psychiatr Genet. 2015;25:139\u201346.","journal-title":"Psychiatr Genet"},{"key":"2911_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamaneurol.2020.3536","volume":"78","author":"BW Kunkle","year":"2021","unstructured":"Kunkle BW, Schmidt M, Klein HU. Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis (vol 78, pg 102, 2021). JAMA Neurol. 2021;78:620.","journal-title":"JAMA Neurol"},{"key":"2911_CR51","first-page":"S465","volume":"38","author":"M Rizig","year":"2023","unstructured":"Rizig M, Ciga SB, Makarious M, Ojo O, Okunoye O, Levine K, et al. Genome-wide association identifies novel etiological insights associated with Parkinson\u2019s disease in African and African admixed populations. Mov Disord. 2023;38:S465\u2013S.","journal-title":"Mov Disord"},{"key":"2911_CR52","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03f54,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309:1483\u201392.","journal-title":"JAMA"},{"key":"2911_CR53","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awac128","volume":"146","author":"J Stevenson-Hoare","year":"2023","unstructured":"Stevenson-Hoare J, Heslegrave A, Leonenko G, Fathalla D, Bellou E, Luckcuck L, et al. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer\u2019s disease. Brain. 2023;146:690\u20139.1.","journal-title":"Brain"},{"key":"2911_CR54","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41588-024-01939-9","volume":"56","author":"LMP Shade","year":"2024","unstructured":"Shade LMP, Katsumata Y, Abner EL, Aung KZ, Claas SA, Qiao Q, et al. GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. Nat Genet. 2024;56:2407\u201321.","journal-title":"Nat Genet"},{"key":"2911_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/hmg\/dds436","volume":"22","author":"R Lemmens","year":"2013","unstructured":"Lemmens R, Maugeri A, Niessen HW, Goris A, Tousseyn T, Demaerel P, et al. Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency. Hum Mol Genet. 2013;22:391\u20137.","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02911-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:03:32Z","timestamp":1747721012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2911"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02911-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"25 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JH has consulted for Eisai and Eli Lilly on their dementia programmes. VEP has no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}